EcoDrugPlus

Tnf Alpha Induced Protein 6

Ensembl ID : ENSOTSG00005027397
Gene Symbol: TNFAIP6
3 Cross references
204 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSOTSG00005041583
Gene Symbol: UGCG
1 Cross references
205 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSOTSG00005005384
Gene Symbol: UGCG
1 Cross references
204 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSOTSG00005008918
Gene Symbol: WEE1
1 Cross references
142 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSOTSG00005006403
Gene Symbol: WEE1
3 Cross references
142 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSOTSG00005035632
Gene Symbol: WEE1
1 Cross references
199 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSOTSG00005015231
Gene Symbol: WEE1
1 Cross references
199 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSOTSG00005010781
Gene Symbol: YES1
3 Cross references
200 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSOTSG00005026315
Gene Symbol: YES1
1 Cross references
200 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSOTSG00005011056
Gene Symbol: ACHE
1 Cross references
227 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSOTSG00005037202
Gene Symbol: ACHE
1 Cross references
227 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSOTSG00005033044
Gene Symbol: ACVR2BA
1 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).